BEIJING SCITOP BIO revenue breakdown overview

BEIJING SCITOP BIO revenue for the last year amounted to 302.79 M CNY, the most of which — 231.63 M CNY — came from its highest performing source at the moment, Edible Probiotic Products, the year earlier bringing 191.67 M CNY. The greatest contribution to the revenue figure was made by China — last year it brought BEIJING SCITOP BIO 297.18 M CNY, and the year before that — 293.72 M CNY.